close x
Stay Up to date with MM&M Events

Join our
mailing list

Thank you!
Your submission has been received!

Oops! Something went wrong while submitting the form

scroll arrow


New York City
Eventi Hotel
851 6th Ave
May 17, 2018
New York City
Eventi Hotel
851 6th Ave
May 17, 2018


WElcome to the 4th Annual MM&M Transforming Healthcare Conference

Going Beyond The Pill

True transformation requires sharing ideas, data, AND new technology
among biopharma, payers, providers and patients

  The 2018 conference brings together an ecosystem of healthcare stakeholders fully committed to demonstrating real-world evidence, making the shift to value-based care, and accelerating innovation along the lifecycle.

Through intense exploration of key technologies, thought-provoking panels, and beyond-the-pill case studies, this one-day event encourages us to think outside the biopharma box. It’s the perfect environment to reexamine commercial strategy, learn from startups with intuitive customer interfaces, and explore the value-proposition of adjacent or complementary services. Join us in the reshaping of digital health strategy and the creation of a new business model that will bring us closer to an X-pill reality!

what's in store for 2018?

Leadership Image
Thought Leadership

We will be joined by over 20+ industry leading speakers from Pharmaceutical Companies, Pharma Marketing Agencies and BioTech Companies covering the ins and out on how to take your marketing strategies beyond the pill.

Innovation Image

This not to be missed opportunity will provide the latest innovative and transformative pitches from start-ups to industry natives at this year's Shark Tank session.


Join us throughout the day for key networking opportunities at our breakfast, luncheon, and, cocktail receptions.

Highlights from 2017

See what you missed in 2017

 On May 1, 2017 the biggest players in the digiceuticals world—from health-tech startups, to the investor community, government and the giants in healthcare— came together to engage in another day of exploring ways to go beyond the pill at the 3rd annual MM&M Transforming Healthcare Conference. Watch our video highlights from our event.

2018 advisory board

MM&M has worked with our newly formed advisory board to bring you
cutting-edge examples of innovation and content that has been specifically curated for you

Stephanie Bova
stephanie bova

Head of Europe and Canada and head of global operations, digital accelerator, Takeda

Joe Sheilds
Dan GAndor

Director, digital innovation and corporate program management, Takeda

Shween Gwee
Shwen Gwee

general manager, digital accelerator, Novartis Pharmaceuticals

Stephanie Bova
Jay Rajda, MD MBA, FACP

Chief clinical transformation officer, Aetna

Meghan Rivera
Meghan Lopresto-Rivera

VP, digital marketing, AMAG Pharmaceuticals

Joe Sheilds

Sr. director, global strategy & innovation, AstraZeneca

KEynote speaker

Greg Simon

President, Biden Cancer Initiative

Greg Simon is the President of the Biden Cancer Initiative. He previously served as the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama and for which he was chosen by Vice President Joe Biden in March 2016. 

learn more

Daniel J. Gandor

director, digital innovation and corporate program management, Takeda

Daniel J. Gandor is the Director, Digital Innovation and Corporate Program Management at Takeda. Prior to this role, Dan was the US Head of the Takeda Digital Accelerator where he spearheaded the efforts to identify opportunities for game-changing digital disruption within healthcare in order to better support and activate patients in managing their diseases and treatments. The Digital Accelerator not only explores digital futures, but supports scalable experiments to pinpoint and accelerate best practices, thereby catalyzing innovation.

learn more

Geeta Wilson

vice president, consumer experience - enterprise transformation, Humana

As the founder of Humana’s FastStart Consumer Experience lab, Geeta Wilson has built an enterprise customer-centric movement that challenges convention and corporate routines. Her FastStart team has brought its disruptive CX approach to 5,000+ associates and 1,000+ leaders using methods from Lean Start-up, Agile/Scrum, Design Thinking, and Lean Six Sigma to expedite speed-to-market across all lines of business.

learn more


*agenda subject to change

9:00 AM

8:00 to 9:00 AM

Breakfast and Registration

9:05 AM

9:00 to 9:05 AM

Welcome Remarks

9:35 AM

9:05 to 9:35 AM

Bridging the Patient-Industry Data Divide

There is so much promise, not only in what we can accomplish in the fight against cancer, but in so many areas of health and medicine, but we need to get out of our own way and focus on patient outcomes as our north star. Greg Simon shares on lessons learned from the White House Cancer Moonshot, and opportunities to make the system work better for patients – including standardizing, sharing, and putting the power of data in the patient’s hands.

Greg Simon, President, Biden Cancer Initiative

10:10 AM


9:40 to 10:10 AM

Speaking Human - The Enduring Power of
Communication in Healthcare’s Age of Machines

As technology continues to rewire, remake and remodel both the business and experience of healthcare, how can brands and their partners hope to stay relevant in an age of exponential change?

Drawing on experience both in and out of healthcare, and supported with data from a recent Syneos Health global survey of patient attitudes towards artificial intelligence, Duncan will separate the hype from the hope and set the stage for a day focused on an enduringly human, patient-inspired vision of the future of healthcare communications.

Duncan Arbour, SVP, innovation, Syneos Health Communications

10:45 AM

Morning Networking and Coffee Break

12:05 PM

10:45  to 12:05 Pm


Case studies that feature commercial strategy behind innovative therapies.


Case study Track 2:

Squarespace for Pharma

10:45 -11:10 AM

Sponsored By:

Biosimilars are disrupting the biologics industry in Europe. Fingerpaint is adapting to trends in communications technology to prepare for that disruption as it comes to the United States.

Phil Storer, innovation, Fingerpaint
Deb Glasser Head of Marketing, Biogen Biosimilars

Managing Treatment for Respiratory Disease in the Cloud

11:10 - 11:35 AM

Michael Seggev leads the consumer marketing for Teva’s global digital respiratory portfolio which will connect respiratory inhalers to patients’ phones and – with their permission – provide insights to their providers that may help improve outcomes.  He’ll describe how Teva plans to address unmet medical needs by transforming inhaler devices into digital health tools that empower patients, caregivers and healthcare providers to address adherence, technique, and other challenges in respiratory care.

Michael Seggev, senior director,
marketing, global respiratory franchise, Teva Pharmaceuticals

Track and Remind: Can Connected Medical Devices Improve Medication Adherence

11:35 - 12:00 PM

Tracking and reminding, how connected devices improve patient medication adherence. Given the recognized problem of adherence to preventive medication, Adherium’s Smartinhaler™ platform demonstrates its ability to improve patient engagement and treatment effectiveness.

Vik Panda, VP, marketing, Adherium

Scaling not Failing with Patient Services

10:45 - 11:10 AM

Building patient services for multiple health conditions, patient segments or geographies requires a different mindset from the start. Failure is often an important part of the process to cross the chasm that separates a simple pilot from a full-scale rollout. Learn how--and how not to--design, develop, deliver and distribute patient solutions that truly scale.

Joe Shields, sr. director, global strategy & innovation, ASTRAZENECA                                                                                                                                                                           

reSET-ing Healthcare with a Prescription Digital Therapeutic

11:10 - 11:35 AM

PEAR Therapeutics will address the key initiatives they are undertaking in an effort to launch and commercialize the first FDA cleared prescription digital therapeutic to treat substance use disorder. Chris and Everett will review, in depth, the opportunities and challenges they are addressing in an effort to bring a clinically validated novel technology to patients, providers and payers.

Christopher S. Lento
, MBA, vice president, commercial operations, Pear Therapeutics;
Everett Crosland, J.D., M.SC, executive director, market access & reimbursement, Pear Therapeutics

New models for patient-centric digital communication

11:35 - 12:00 PM

This session will cover new models of patient-centric digital communications.We will first present how successful co-creation with patients of products and services entails a close collaboration from early discovery to the market. We will then review emerging consumer trends and new initiatives in wearables and mobile health.
Dr. Francoise Simon, senior faculty, Mount Sinai School of Medicine
Sandipa Dublish, sr. director market research - inflammation & immunology, Celgene

1:00 PM


1:40 PM

1:00 to 1:40 PM

Is the Future of Healthcare Voice Activated?

People today are hyper-connected and have unlimited access to information via the internet, social networks and messaging platforms. And now, chat and voice bots are not only changing the future of healthcare support, but also fit perfectly into the traditional process for curating and disseminating healthcare information.

Discover how digital health startups are leveraging AI-driven "conversations” and collaborating with health and biopharma companies to re-imagine the patient and HCP journeys through messaging and voice channels.

Shwen Gwee, general manager, digital accelerator, Novartis Pharmaceuticals
Tony Alvarez, interim digital lead, senior vice president, global human health,Merck
Bill Rogers, co-founder and CEO, Orbita

Moderator: Sara Holoubek, CEO, Luminary



1:45 to 2:10 PM


This dynamic session examines disruption in the US healthcare system, its impact on value networks and whether or not our current operating systems need to accelerate or decelerate. Learn more about the shift in stakeholders, their value and influence, who will be displaced and what alliances or change architecture will be necessary to survive.

Amar Urhekar, president, McCann Health Americas
Simon Miller, global brand director, connected care,  Eli Lilly
Perin Registre, access solutions marketing lead, Genentech

2:35 PM


2:10 to 2:35PM

Monitoring, Managing & Mentoring:
Digital that improves patient lives

As biopharmas scale up their data resources, are some backing off partnerships? Can they really do it on their own? This session explores the latest in data partnership trends to see what has proven most successful.

Chris Zant, Deloitte Digital Leader, Life Sciences

3:00 PM

Afternoon Networking and Coffee Break

3:40 PM


2:35 to 3:00 Pm
Sponsored By:

The Payer’s Seat at the Digital Health Table

This lively discussion gives marketers from the pharma, biotech, and devices sectors the unique opportunity to poise their questions to a panel of insurers, as they discuss their role in boosting patient-level outcomes.

Geeta Wilson, vice president, consumer experience - enterprise transformation, Humana
Dr. Theodore Search, founder and CEO, Skipta
Clifford Jones, CEO, AllazoHealth

Moderator: Marc Iskowitz, editor in chief, MM&M

4:30 PM


3:45 TO 4:30 PM

The healthcare Roundup

This panel brings together key healthcare stakeholders to discuss technology as a driver in increasing collaboration among pharma, payers, providers, pharmacy, and patients. Learn how the healthcare ecosystem is working toward value-based care, and accelerating innovation along the product lifecycle.

Rob Blazek, RPh senior vice president, Networks and Analytics, Rx EDGE Pharmacy Networks
Dan Gandor, director, digital innovation and corporate program management, Takeda
Yauheni  Solad, MD, MHS, medical director, digital health, Yale New Haven Health
Rachael Jones, VP, commercial analytics insights P&L and client management, Anthem

Moderator: Larry Dobrow, senior editor, MM&M

5:15 PM


4:35 to 5:15 PM

A Vision for Innovation: A Look at Pharma’s Top Investors

This panel probes into some of the most active investors in the digital health space- drug manufacturers. Learn what drives big pharma and their VC arms.

Bozidar Jovicevic, vice president, global head digital medicines, Sanofi
Polina Hanin, Moonshot Academy director, StartUp Health
Steve Brash, managing partner, Dreamit Ventures

5:35 PM

5:15 TO 5:30 PM

Closing INSIGHT Keynote

This closing keynote shares opportunities for biopharma innovation with the entry of data and tech-savvy companies like Amazon Web Services (AWS) into the healthcare market. Shaun will share artificial intelligence and machine learning use cases, as well as best practices on data access and provider integration. Learn about imperatives and infrastructure changes biopharma should consider with this change in tide.

Shaun Qualheim, solutions architect, Amazon Web Services

6:30 PM

5:30 PM - 6:30 PM

Cocktail Networking Reception

Ticket Pricing

Registration now open!

Are you a *Pharma Brand Marketer? A limited number of complimentary passes are available for Pharma brand marketers. Click here to request a PharmaPass.
*You must be a marketing professional working at pharmaceutical, biotech, medical device and diagnostic manufacturers to be eligible for a PharmaPass

individual tickets
check mark

Full conference pass

check mark

Key networking opportunities
at our breakfast, luncheon, and, cocktail receptions

groups 3+
check mark

$100 off individual tickets

check mark

Full conference pass

check mark

Key networking opportunities
at our breakfast, luncheon, and, cocktail receptions

For groups 6 or more contact for rates.



Praesent a turpis sit amet massa bibendum laoreet eu sit amet lacus.  


Your submission has been received!
You'll get an email with instructions to complete your purchase

Oops! Something went wrong while submitting the form, please try again...


Hotel Eventi,
851 6th Ave
NY, NY 10001


851 6th Ave
New York, New York 10001

more information


follow us